Max Kopp, a 17-year-old researcher, is exploring the potential of AI-driven noninvasive glucose monitoring technology to revolutionize diabetes care.
Kopp's research focuses on developing a wearable, flexible biosensor that can detect glucose levels through the skin without any punctures, utilizing AI-powered analytics to improve accuracy.
The current monitoring solutions for diabetes present challenges due to their high costs and limited accessibility, and Kopp aims to provide a cost-effective, comfortable, and highly accurate alternative.
If successful, Kopp's research could pave the way for AI-driven glucose monitoring systems to become the new standard in diabetes care, offering a more innovative and accessible approach.